36.3
Xeris Biopharma Holdings, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
87.6
FY23:
135
FY24:
166
FY25:
249
(positive)
Change from FY21 to FY25
millions USD
FY21:
−115
FY22:
−81.9
FY23:
−44.0
FY24:
−33.6
FY25:
24.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−113
FY22:
−66.7
FY23:
−26.1
FY24:
−15.7
FY25:
42.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−123
FY22:
−96.1
FY23:
−63.5
FY24:
−57.1
FY25:
0.55
(positive)
Change from FY21 to FY25
millions USD
FY21:
−123
FY22:
−94.7
FY23:
−62.3
FY24:
−54.8
FY25:
0.55
All amounts in millions USD